According to the latest report by IMARC Group, titled, “Anti-Rheumatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the — global anti-rheumatics market exhibited moderate growth during 2015-2020. Looking forward, the market expects to grow at a CAGR of around 4% during 2021-2026.
Anti-rheumatics refer to the medications that are used for treating rheumatoid arthritis, a chronic inflammatory medical condition. Anti-rheumatic drugs are commonly prescribed by healthcare professionals to halt the disease progression. Apart from this, it is also utilized to treat inflammatory myositis, bowel diseases, and cancer.
Get a PDF Sample for more detailed market insights:
The global market is majorly driven by the increasing incidences of rheumatoid arthritis across the globe. Along with this, the widespread adoption of biosimilars and novel biologic therapies among the masses is also contributing to the market growth. Moreover, the rising prevalence of acute and chronic medical conditions, such as systemic sclerosis, systematic lupus erythematosus, and Sjogren syndrome, is providing a boost to the demand for anti-rheumatics across the globe. Other factors, including the increasing investments by public and private firms to upgrade the existing healthcare infrastructure and extensive research and development (R&D) activities conducted by key players, are driving the market growth further.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The competitive landscape of the industry has also been examined along with the profiles of the key players.
AbbVie Inc. (ABBV)
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche AG
Johnson & Johnsons
Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/anti-rheumatics-market
The report has segmented the market on the basis of Type, Drug Class, Route of Drug Administration, Distribution Channel and Region.
Breakup by Type:
Breakup by Drug Class:
Disease Modifying Anti-Rheumatics Drugs (DMARD’s)
Nonsteroidal Anti-Inflammatory Drugs (NSAID’s)
Uric Acid Drugs
Breakup by Route of Drug Administration:
Breakup by Distribution Channel:
Breakup by Region:
Middle East and Africa
Browse related reports:
India Generic Injectables Market Report: https://www.imarcgroup.com/india-generic-injectables-market
Nanorobotics Market Report: https://www.imarcgroup.com/nanorobotics-market
Health Insurance Market Size: https://www.imarcgroup.com/health-insurance-market
Freeze-Drying Equipment Market Report: https://www.imarcgroup.com/freeze-drying-equipment-market
Portable Oxygen Concentrators Market Size: https://www.imarcgroup.com/portable-oxygen-concentrators-market
Carbon Dioxide Incubators Market Report: https://www.imarcgroup.com/carbon-dioxide-incubators-market
Alzheimer’s Drugs Market Report: https://www.imarcgroup.com/alzeimers-drugs-market
Blood Culture Test Market Report: https://www.imarcgroup.com/blood-culture-test-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Release ID: 89041464